| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8790031 | Urologic Oncology: Seminars and Original Investigations | 2018 | 7 Pages |
Abstract
Our findings failed to confirm that combination of ADT at RT reduces CSM rates in high metastatic risk PCa patients aged 80 years or more. Moreover, combination of ADT at RT resulted in a significant cost increase, relative to RT alone.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Paolo M.D., Marco M.D., Sami-Ramzi M.D., Zhe B.Sc., Vincent M.D., Alessandro M.D., Nicola M.D., Marco M.D., Giorgio M.D., Umberto M.D., Alberto M.D., Markus M.D., Francesco M.D., Fred M.D., Pierre I. M.D.,